Merck & Co., Inc. (MRK)
108.83
-2.14
(-1.93%)
USD |
NYSE |
Jan 16, 16:00
109.18
+0.35
(+0.32%)
After-Hours: 20:00
Merck Market Cap: 270.12B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 177.92B |
| Gilead Sciences, Inc. | 154.97B |
| Regeneron Pharmaceuticals, Inc. | 77.04B |
| Cidara Therapeutics, Inc. | 6.962B |
| Moderna, Inc. | 16.34B |
Market Cap Related Metrics
| PE Ratio | 14.40 |
| PS Ratio | 4.292 |
| PEG Ratio | 0.2468 |
| Price to Book Value | 5.210 |
| Price to Free Cash Flow | 21.02 |
| Price | 108.83 |
| Earnings Yield | 6.95% |
| PEGY Ratio | 0.2347 |
| Operating PE Ratio | 10.79 |
| Normalized PE Ratio | 12.74 |